With the growing pipeline of biologics, increase in vaccine production, and trends toward smaller batch sizes targeting smaller patient populations, there is increasing demand for advanced manufacturing technologies. These parenteral drugs require advanced facilities and equipment for fill/finish operations to ensure product quality and safety. As pharmaceutical, biotech companies, and contract development and manufacturing organizations (CDMOs) look to build or expand manufacturing capabilities, there are several factors that need to be evaluated: maximization of floorspace, reduced risk of cross-contamination, manufacturing flexibility, varying throughput, tech transfer, and various primary packaging formats. Today’s fill/finish equipment technologies present various options to meet many of today’s manufacturing requirements.